Early screening for autism risk in infants at maternal and child protection services
Compares two screening methods to find infants at risk of autism and neurodevelopmental disorders.
Plain-language title generated from the registry record
Registry title: Early Detection and Referral for Autism and Neurodevelopmental Disorders at the Maternal and Child Protection Services
Key facts
- Where
- Champigny-sur-Marne, FranceSee the site
Where in France
- PMI StalingradChampigny-sur-Marne, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centre Hospitalier Intercommunal Creteil
- Trial code
- NCT05815095
- Record updated
- 13 June 2025
- Original description
This study aims to compare two screening strategies for identifying infants with a potential risk of Autism Spectrum and Neurodevelopmental Disorders to provide early access to care and increase the likelihood of a favorable outcomeRead full original descriptionShow less
Randomized Pragmatic, Cluster, Stepped-wedge Trial of Early Detection and Referral for Autism and Neurodevelopmental Disorders at the Maternal and Child Protection Services for Care Before 1 Year of Follow-up
This study aims to compare two screening strategies for identifying infants with a potential risk of Autism Spectrum and Neurodevelopmental Disorders to provide early access to care and increase the likelihood of a favorable outcome
Inclusion: Infants between 4 and 9 months of age followed up in the participating Maternal and Child Protection Services for the fourth and ninth-month mandatory vaccinations; Availability of a personnel telephone for at least one parent; Information to the parents for data collection and the active follow-up of the child until 36 months and express consent to participate in the research; Affiliation to a social security system or benefiting from the Medical assistance of the state; Mastery of a minimum of French according to the principal investigator or the presence of a French-speaking relative.
Exclusion: Infant with a severe neurological pathology such as encephalopathy; Refusal to participate in the study.